These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1. Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443 [TBL] [Abstract][Full Text] [Related]
47. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus. Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282 [TBL] [Abstract][Full Text] [Related]
48. Fundamentals of cross-seeding of amyloid proteins: an introduction. Ren B; Zhang Y; Zhang M; Liu Y; Zhang D; Gong X; Feng Z; Tang J; Chang Y; Zheng J J Mater Chem B; 2019 Dec; 7(46):7267-7282. PubMed ID: 31647489 [TBL] [Abstract][Full Text] [Related]
49. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research. Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514 [TBL] [Abstract][Full Text] [Related]
50. Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer's disease: two triggers, one disease. Ferreira S; Raimundo AF; Menezes R; Martins IC Neural Regen Res; 2021 Jun; 16(6):1127-1130. PubMed ID: 33269760 [TBL] [Abstract][Full Text] [Related]
51. Heat shock protein 90 in Alzheimer's disease. Ou JR; Tan MS; Xie AM; Yu JT; Tan L Biomed Res Int; 2014; 2014():796869. PubMed ID: 25374890 [TBL] [Abstract][Full Text] [Related]
52. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
53. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease. Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389 [TBL] [Abstract][Full Text] [Related]
54. Liraglutide Protects Against Brain Amyloid-β Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329 [TBL] [Abstract][Full Text] [Related]
55. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease. Ahmed AS; Elgharabawy RM; Al-Najjar AH Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431 [TBL] [Abstract][Full Text] [Related]
56. Stress proteins in Alzheimer's disease. Smith RC; Rosen KM; Pola R; Magrané J Int J Hyperthermia; 2005 Aug; 21(5):421-31. PubMed ID: 16048839 [TBL] [Abstract][Full Text] [Related]
57. Hypothesis and Theory: Circulating Alzheimer's-Related Biomarkers in Type 2 Diabetes. Insight From the Goto-Kakizaki Rat. Movassat J; Delangre E; Liu J; Gu Y; Janel N Front Neurol; 2019; 10():649. PubMed ID: 31293498 [TBL] [Abstract][Full Text] [Related]
58. βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease. Audrain M; Souchet B; Alves S; Fol R; Viode A; Haddjeri A; Tada S; Orefice NS; Joséphine C; Bemelmans AP; Delzescaux T; Déglon N; Hantraye P; Akwa Y; Becher F; Billard JM; Potier B; Dutar P; Cartier N; Braudeau J Cereb Cortex; 2018 Nov; 28(11):3976-3993. PubMed ID: 29048465 [TBL] [Abstract][Full Text] [Related]
59. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease. Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985 [TBL] [Abstract][Full Text] [Related]
60. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]